Accéder au contenu
Merck
Toutes les photos(1)

Principaux documents

MHS128

Sigma-Aldrich

Mayer′s Hematoxylin Solution

Synonyme(s) :

(6aS,11bR)-7,11b-Dihydroindeno[2,1-c]chromene-3,4,6a,9,10(6H)-pentol, Delafield′s hematoxylin, Progressive stains

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme

Sélectionner une taille de conditionnement

4 L
271,00 €

271,00 €


Check Cart for Availability

Devis pour commande en gros

Sélectionner une taille de conditionnement

Changer de vue
4 L
271,00 €

About This Item

Numéro MDL:
Code UNSPSC :
41116124
ID de substance PubChem :
Nomenclature NACRES :
NA.47

271,00 €


Check Cart for Availability

Devis pour commande en gros

Forme

solution

Durée de conservation

Expiry date on the label.

IVD

for in vitro diagnostic use

Concentration

1 g/L

pH

2.4 (25 °C)

Application(s)

hematology
histology

Température de stockage

room temp

Chaîne SMILES 

Oc1cc2C[C@@]3(O)COc4c(O)c(O)ccc4[C@H]3c2cc1O

InChI

1S/C16H14O6/c17-10-2-1-8-13-9-4-12(19)11(18)3-7(9)5-16(13,21)6-22-15(8)14(10)20/h1-4,13,17-21H,5-6H2/t13-,16+/m0/s1

Clé InChI

WZUVPPKBWHMQCE-XJKSGUPXSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

Used as a counterstain for procedures such as immunohistochemistry or laser microdissection.

Application

General purpose nuclear stain, progressive type. Used with hematoxylin and eosin staining.

Autres remarques

1 g/L certified hematoxylin

Code de la classe de stockage

12 - Non Combustible Liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Shun-Jie Chen et al.
Oncology reports, 37(2), 1148-1158 (2016-12-14)
Acute kidney injury (AKI) is a disease where kidney function is lost almost instantaneously; it can develop very rapidly over few hours to maximum of few days. Despite the advent of technology, the clinical management against this disease is very
Stephany Orjuela et al.
BMC cancer, 20(1), 290-290 (2020-04-08)
Identifying molecular differences between primary and metastatic colorectal cancers-now possible with the aid of omics technologies-can improve our understanding of the biological mechanisms of cancer progression and facilitate the discovery of novel treatments for late-stage cancer. We compared the DNA
Adam Smith et al.
Molecular cancer therapeutics, 8(6), 1666-1675 (2009-06-11)
Although viridins like wortmannin (Wm) have long been examined as anticancer agents, their ability to self-activate has only recently been recognized. Here, we describe the cytostatic effects of a self-activating viridin (SAV), which is an inactive, polymeric prodrug. SAV self-activates
Hideki Ishii et al.
Bioorganic & medicinal chemistry letters, 22(3), 1469-1474 (2012-01-17)
SAR studies for the exploration a novel class of anti-human immunodeficiency virus type 1 (HIV-1) agents based on the hematoxylin structure (1) are described. The systematic deoxygenations of 1 including asymmetric synthesis were conducted to obtain a compound showing high
Li-Gen Lin et al.
Journal of medicinal chemistry, 51(15), 4419-4429 (2008-07-10)
Protein tyrosine kinase (PTK) inhibitors represent emerging therapeutics for cancer chemoprevention. In our study, hematoxylin (26) was identified as one of the most remarkable c-Src inhibitors in an orthogonal compound-mixing library (32200 compounds) by using an ELISA-based automated high-throughput screening

Questions

1–6 sur 6 questions  
  1. What is the Department of Transportation shipping information for this product?

    1 réponse
    1. Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.

      Utile ?

  2. There are several Mayer's Hematoxylins listed on the website, beginning with the letters MHS.  What are the differences?

    1 réponse
    1. Products MHS1, MHS16, MHS32, MHS80 and MHS128 are in fact the same product. In this case a unique product number was assigned to each package size. Other than the package size, there are no differences in formulation or use.

      Utile ?

  3. There is also a product listed on the website as Hematoxylin Solution According to Mayer. What is the difference between product 51275 and the various Mayer's Hematoxylin solutions?

    1 réponse
    1. The basic formulations are the same. Both include chloral hydrate, although some of the concentrations could vary slightly. Product 51275 is not intended for In Vitro Diagnostic Use. Product 51275 is not CE Marked. The various Mayer's Hematoyxlin solutions are intended For In Vitro Diagnostic Use and are also CE Marked. Product inserts are available for various languages.

      Utile ?

  4. The slides were stained with Mayer's Hematoxylin but the nuclei are not blue. Why?

    1 réponse
    1. The nuclei will originally appear as the same color as the solution. Only after the slides have been "blued" will the nuclei appear blue. The pH of the solution is acidic. This acidic pH promotes specific staining. However the slides must be washed in an neutral or alkaline solution for the color to shift to blue. Prolonged warm water washes in tap water are often sufficient for the bluing to occur. To shorten the time spent in washing, various bluing agents are often used to shorten the blueing process. Scott's Tap Water Substitute (Product No. S5134) is one such blueing agent.

      Utile ?

  5. The website states that Mayer's Hematoxylin solution is a progressive type hematoxylin. What is a progressive type hematoxylin?

    1 réponse
    1. Hematoxylin solutions are generally classified as either progressive or regressive. Progressive formulations will stain only the nucleus. No staining should occur within the cytoplasm. Regressive hematoxylins have higher dye contents and if used for sufficient periods of time will overstain both the nucleus and the cytoplasm. Acid differentiation is required to remove the excessive stain from the cytoplasm and nucleus. This differentiation take practice to master. Too much or too little stain can be removed during differentiation, resulting in poorly stained slides. For users lacking extensive experience with the Hematoxylin and Eosin staining procedure,  progressive hematoxylin formulations are often the better choice.

      Utile ?

  6. Is chloral hydrate used in the preparation of Mayer's Hematoxylin?  Does this mean the solution is controlled as a DEA Schedule IV product?

    1 réponse
    1. Yes, chloral hydrate is included in the formulation. No, the solution is not controlled as a DEA Schedule IV product. Once the choral hydrate is mixed with the remaining chemicals, it is impossible to obtain the chloral hydrate in a purified form.

      Utile ?

Évaluations

Aucune valeur de notation

Filtres actifs

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique